• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

7C8:GR

0.035 EUR 0.003 7.89%

As of 02:27:44 ET on 07/11/2014.

Snapshot for Invion Ltd (7C8)

Open: 0.035 Day's Range: 0.035 - 0.035 Volume: 0
Previous Close: 0.038 52wk Range: 0.011 - 0.083 1-Yr Rtn: +192.37%

Stock Chart for 7C8

No chart data available.
  • 7C8:GR 0.035
  • 1D
  • 1M
  • 1Y
0.038
Interactive 7C8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 7C8

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 18.94
Shares Outstanding (M) 541.23
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 7C8

No data available

Company Profile & Key Executives for 7C8

Invion Limited develops pharmaceutical products for the treatment of asthma and smoking cessation. The Company also is involved in the treatment autoimmune and inflammatory diseases, such as rheumatoid arthritis.

Gregory CollierCEO/Managing DirectorTom CooganChief Financial Officer
Mitchell GlassVP:R&D/Chief Medical OfficerJames CampbellExecutive Director
More Company Profile & Key Executives for 7C8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil